Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EF5 for Detecting Tumor Hypoxia and Vascularity in Intraperitoneal Photodynamic Therapy
NCT00028782Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Oct 2001
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etanidazole in malignant mesothelioma, malignant ascites, primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started Oct 2001; status: terminated.
02
Drugs
etanidazole
03
Conditions
malignant mesotheliomamalignant ascitesprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00028782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028782.